Fragility Index and Fragility Quotient in Randomized Controlled Trials on Corticosteroids in ARDS Due to COVID-19 and Non-COVID-19 Etiology

Fragility Index and Fragility Quotient in Randomized Controlled Trials on Corticosteroids in ARDS Due to COVID-19 and Non-COVID-19 Etiology

Background: The effectiveness of corticosteroids in acute respiratory distress syndrome (ARDS) and COVID-19 still remains uncertain. Since ARDS is due to a hyperinflammatory response to a direct injury, we decided to perform a meta-analysis and an evaluation of robustness of randomised clinical tria...

Full description

Bibliographic Details
Main Authors: Maria Vargas, Annachiara Marra, Pasquale Buonanno, Antonio Coviello, Carmine Iacovazzo, Giuseppe Servillo
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Journal of Clinical Medicine
Subjects:
COVID-19
acute respiratory distress syndrome (ARDS)
corticosteroid
pneumonia
fragility index
fragility quotient
Online Access:https://www.mdpi.com/2077-0383/10/22/5287

Internet

https://www.mdpi.com/2077-0383/10/22/5287

Similar Items